Formula 1: McLaren Racing to provide Sanofi (FRA) with analytical tools to optimise production

Sanofi, a French pharmaceutical group, has entered into a multi-year partnership with McLaren Racing "to accelerate industrial excellence," announced the two parties on 26/04/2022.

As part of this partnership, the Formula 1 team will provide Sanofi with its McLaren Accelerator technology solution. "McLaren Racing will bring its digital and analytical expertise and skills to help Sanofi teams focus on major items impacting performance, and better anticipate and resolve them. Modelling simulation of production line changeovers and operations will be key areas of McLaren's Formula 1 experience, as exemplified using advanced data analytics and expertise used to optimize the famed pit stops of F1 races," said Sanofi and the British team.

During the pandemic, the two companies had previously collaborated to produce and supply artificial respirators. "Following a successful pilot in 2021 with McLaren Racing, both companies have decided to extend their collaboration across multiple sites in seven countries, covering more than 100 production lines, across all technologies. Learnings from this…